StockNews.com assumed coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a research note issued to investors on Monday morning. The firm issued a sell rating on the biotechnology company’s stock.
22nd Century Group Stock Performance
Shares of XXII opened at $0.10 on Monday. 22nd Century Group has a 1 year low of $0.08 and a 1 year high of $5.28. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.09 and a quick ratio of 0.93. The stock’s fifty day moving average price is $0.15 and its two-hundred day moving average price is $0.53. The firm has a market cap of $4.80 million, a PE ratio of 0.00 and a beta of 1.45.
22nd Century Group (NASDAQ:XXII – Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.54) EPS for the quarter. The business had revenue of $5.95 million for the quarter. 22nd Century Group had a negative net margin of 144.09% and a negative return on equity of 380.39%.
Institutional Investors Weigh In On 22nd Century Group
About 22nd Century Group
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Featured Articles
- Five stocks we like better than 22nd Century Group
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- 3 Healthcare Dividend Stocks to Buy
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Capture the Benefits of Dividend Increases
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.